Skip to main content

Advertisement

Log in

Primary CD56+ NK/T-cell lymphoma of the rectum accompanied with refractory ulcerative colitis

  • Case Report
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

A case of primary NK/T-cell lymphoma of the rectum accompanied with ulcerative colitis (UC) in a 73-year-old man is reported. He had a 6-year history of repeated admission to our hospital for UC. Total colonoscopy performed 4 months after resolution of refractory UC complicated by cytomegalovirus colitis showed a markedly submucosal tumor in the rectum, which was histologically diagnosed as malignant lymphoma. The findings of computed tomography of the chest and abdomen, gallium scintigraphy, abdominal ultrasonography, and upper gastrointestinal endoscopy showed no abnormal lesions. Therefore, based on a diagnosis of localized rectal lymphoma with UC, proctocolectomy was performed. The resected specimen showed three submucosal tumors in the rectum with local nodal involvement. Histologically, the tumors were characterized by diffusely infiltrating sheets of large atypical lymphoid cells, which were negative for CD4, CD8, and CD20 but were positive for CD56, CD3, and granzyme B. The presence of Epstein-Barr virus (EBV) infection in neoplastic cells was shown by in situ hybridization for EBV-encoded early small RNA1 (EBER-1). Based on these findings, the patient was diagnosed with primary CD56+ NK/T-cell lymphoma of the rectum (stage IIE). This is the first case report of primary rectal NK/T-cell lymphoma accompanied with UC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kewenter J, Ahlman H, Hulten L. Cancer risk in extensive ulcerative colitis. Ann Surg 1978;188:824–828.

    Article  PubMed  CAS  Google Scholar 

  2. Prior P, Gyde SN, Macartney JC, Thompson H, Waterhouse JA, Allan RN. Cancer morbidity in ulcerative colitis. Gut 1982;23:490–497.

    Article  PubMed  CAS  Google Scholar 

  3. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526–535.

    Article  PubMed  CAS  Google Scholar 

  4. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990;323:1228–1233.

    PubMed  CAS  Google Scholar 

  5. Greenstein AJ, Mullin GE, Strauchen JA, Heimann T, Janowitz HD, Aufses AH Jr, et al. Lymphoma in inflammatory bowel disease. Cancer (Phila) 1992;69:1119–1123.

    CAS  Google Scholar 

  6. Lewis JD, Bilker WB, Brensinger C, Deren JJ, Vaughn DJ, Strom BL. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 2001;121:1080–1087.

    Article  PubMed  CAS  Google Scholar 

  7. Shepherd NA, Hall PA, Coates PJ, Levison DA. Primary malignant lymphoma of the colon and rectum. A histopathological and immunohistochemical analysis of 45 cases with clinicopathological correlations. Histopathology (Oxf) 1988;12:235–252.

    Article  CAS  Google Scholar 

  8. Grody WW, Magidson JG, Weiss LM, Hu E, Warnke HA, Lewin KJ. Gastrointestinal lymphomas. Immunohistochemical studies on the cell of origin. Am J Surg Pathol 1985;9:328–337.

    Article  PubMed  CAS  Google Scholar 

  9. Kim HS, Lee DK, Baik SK, Kwon SO, Cho MY, Ko YH. Primary CD56+ T/NK cell lymphoma of the colon. J Gastroenterol 2002;37:939–946.

    Article  PubMed  Google Scholar 

  10. Lanier LL, Chang C, Spits H, Phillips JH. Expression of cytoplasmic CD3 epsilon proteins in activated human adult natural killer (NK) cells and CD3 gamma, delta, epsilon complexes in fetal NK cells. Implications for the relationship of NK and T lymphocytes. J Immunol 1992;149:1876–1880.

    PubMed  CAS  Google Scholar 

  11. Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89:4501–4513.

    PubMed  CAS  Google Scholar 

  12. Wong NA, Herbst H, Herrmann K, Kirchner T, Krajewski AS, Moorghen M, et al. Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas. J Pathol 2003;201:312–318.

    Article  PubMed  CAS  Google Scholar 

  13. Bertalot G, Villanacci V, Gramegna M, Orvieto E, Negrini R, Saleri A, et al. Evidence of Epstein-Barr virus infection in ulcerative colitis. Dig Liver Dis 2001;33:551–558.

    Article  PubMed  CAS  Google Scholar 

  14. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin’s Disease Staging Classification. Cancer Res 1971;31:1860–1861.

    PubMed  CAS  Google Scholar 

  15. Rohatiner A, d’Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994;5:397–400.

    PubMed  CAS  Google Scholar 

  16. Crump M, Gospodarowicz M, Shepherd FA. Lymphoma of the gastrointestinal tract. Semin Oncol 1999;26;324–337.

    PubMed  CAS  Google Scholar 

  17. Au WY, Ma SY, Chim CS, Choy C, Loong F, Lie AK, et al. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Ann Oncol 2005;16:206–214.

    Article  PubMed  Google Scholar 

  18. Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia 2005;19:2186–2194.

    Article  PubMed  CAS  Google Scholar 

  19. Jaffe ES, Chan JK, Su IJ, Frizzera G, Mori S, Feller AC, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103–111.

    Article  PubMed  CAS  Google Scholar 

  20. Ekbom A, Helmick C, Zack M, Adami HO. Extracolonic malignancies in inflammatory bowel disease. Cancer (Phila) 1991;67:2015–2019.

    Article  CAS  Google Scholar 

  21. Loftus EV Jr, Tremaine WJ, Habermann TM, Harmsen WS, Zinsmeister AR, Sandborn WJ. Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol 2000;95:2308–2312.

    Article  PubMed  Google Scholar 

  22. Greenstein AJ, Gennuso R, Sachar DB, Heimann T, Smith H, Janowitz HD, et al. Extraintestinal cancers in inflammatory bowel disease. Cancer (Phila) 1985;56:2914–2921.

    Article  CAS  Google Scholar 

  23. Farrell RJ, Ang Y, Kileen P, O’Briain DS, Kelleher D, Keeling PW, et al. Increased incidence of non-Hodgkin’s lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut 2000;47:514–519.

    Article  PubMed  CAS  Google Scholar 

  24. Dayharsh GA, Loftus EV Jr, Sandborn WJ, Tremaine WJ, Zinsmeister AR, Witzig TE, et al. Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Gastroenterol 2002;122:72–77.

    Article  CAS  Google Scholar 

  25. Fraser AG, Orchard TR, Robinson EM, Jewell DP. Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. Aliment Pharmacol Ther 2002;16:1225–1232.

    Article  PubMed  CAS  Google Scholar 

  26. Connell WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard-Jones JE. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994;343:1249–1252.

    Article  PubMed  CAS  Google Scholar 

  27. Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol 1999;94:3248–3253.

    Article  PubMed  CAS  Google Scholar 

  28. Okada M, Maeda K, Suzumiya J, Hagimoto T, Wakamatsu S, Ohshima K, et al. Primary colorectal T-cell lymphoma. J Gastroenterol 2003;38:376–384.

    Article  PubMed  Google Scholar 

  29. Watanabe N, Sugimoto N, Matsushita A, Maeda A, Nagai K, Hanioka K, et al. Association of intestinal malignant lymphoma and ulcerative colitis. Intern Med 2003;42:1183–1187.

    Article  PubMed  Google Scholar 

  30. Abulafi AM, Fiddian RV. Malignant lymphoma in ulcerative colitis. Report of a case. Dis Colon Rectum 1990;33:615–618.

    Article  PubMed  CAS  Google Scholar 

  31. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1964;15:702–703.

    Article  Google Scholar 

  32. Niedobitek G, Meru N, Delecluse HJ. Epstein-Barr virus infection and human malignancies. Int J Exp Pathol 2001;82:149–170.

    Article  PubMed  CAS  Google Scholar 

  33. Hopwood P, Crawford DH. The role of EBV in post-transplant malignancies: a review. J Clin Pathol 2000;53:248–254.

    Article  PubMed  CAS  Google Scholar 

  34. Ng SB, Lai KW, Murugaya S, Lee KM, Loong SL, Fook-Chong S, et al. Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol 2004;17:1097–1107.

    Article  PubMed  Google Scholar 

  35. Zhang WY, Li GD, Liu WP, Ouyang Q, Ren XC, Li FY, et al. Features of intestinal T-cell lymphomas in Chinese population without evidence of celiac disease and their close association with Epstein-Barr virus infection. Chin Med J (Engl) 2005;118:1542–1548.

    CAS  Google Scholar 

  36. Chan JK, Yip TT, Tsang WY, Ng CS, Lau WH, Poon YF, et al. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 1994;18:938–946.

    Article  PubMed  CAS  Google Scholar 

  37. Yanai H, Shimizu N, Nagasaki S, Mitani N, Okita K. Epstein-Barr virus infection of the colon with inflammatory bowel disease. Am J Gastroenterol 1999;94:1582–1586.

    Article  PubMed  CAS  Google Scholar 

  38. Kambham N, Vij R, Cartwright CA, Longacre T. Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol 2004;28:365–373.

    Article  PubMed  Google Scholar 

  39. Cottone M, Pietrosi G, Martorana G, Casa A, Pecoraro G, Oliva L, et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn’s colitis. Am J Gastroenterol 2001;96:773–775.

    Article  PubMed  CAS  Google Scholar 

  40. Inoue T, Hirata I, Egashira Y, Ishida K, Kawakami K, Morita E, et al. Refractory ulcerative colitis accompanied with cytomegalovirus colitis and multiple liver abscesses: a case report. World J Gastroenterol 2005;11:5241–5244.

    PubMed  Google Scholar 

  41. Spieker T, Herbst H. Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease. Am J Pathol 2000;157:51–517.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kakimoto, K., Inoue, T., Nishikawa, T. et al. Primary CD56+ NK/T-cell lymphoma of the rectum accompanied with refractory ulcerative colitis. J Gastroenterol 43, 576–580 (2008). https://doi.org/10.1007/s00535-008-2192-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-008-2192-7

Key words

Navigation